先見基因
A precision medicine company specializing in gene sequencing and personalized healthcare.
Please wait while we load the page
先見基因科技 is committed to precision medicine, providing high-quality and innovative services to usher in a new era of personalized medicine. Founded in 2014, it originated from academic research and has a technology transfer partnership with National Cheng Kung University. The company specializes in various gene sequencing platform technologies and big data analysis, tailoring sequence platforms and customized testing analysis to different research and mass market needs. In 2018, it pioneered the promotion of the Affymetrix GeneTitan automated multi-genome site chip detection platform from the scientific research field to the mass market. It is the first automated platform with Asian-specific chips, capable of simultaneously detecting over 750,000 sites, and combines genomic medicine with AI big data analysis to provide precise and rapid gene testing services.
The company offers various gene sequencing and analysis services. Contact them to discuss your specific research or personal healthcare needs, and they will tailor a solution using their sequencing platforms and data analysis capabilities.
Choose this if you’re looking for cutting-edge tech from 先見基因科技 that brings innovative AI solutions tailored to your needs.
Pricing information not available
